[
    [
        {
            "time": "2023-04-12",
            "original_text": "财政部对江苏恒瑞医药股份有限公司作出行政处罚，虚构业务事项、账簿设置不规范……19家药企违反会计规定遭处罚其他违规处罚。",
            "features": {
                "keywords": [
                    "行政处罚",
                    "恒瑞医药",
                    "虚构业务",
                    "会计违规"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "财政部对江苏恒瑞医药股份有限公司作出行政处罚，虚构业务事项、账簿设置不规范……19家药企违反会计规定遭处罚其他违规处罚。",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-04-12",
            "original_text": "恒瑞医药今日大宗交易成交18万股，成交价88.98元溢价0.0%。",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "大宗交易",
                    "成交价"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药今日大宗交易成交18万股，成交价88.98元溢价0.0%。",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 2,
                "Entity_Density": 9,
                "Market_Scope": 1,
                "Time_Proximity": 10,
                "Headline_Structure": 4,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-04-12",
            "original_text": "山西证券——医药生物行业周报：长期投资主线创新与消费升级不变，关注一季报业绩发布【行业研究】",
            "features": {
                "keywords": [
                    "山西证券",
                    "医药生物",
                    "创新",
                    "消费升级",
                    "一季报"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "山西证券——医药生物行业周报：长期投资主线创新与消费升级不变，关注一季报业绩发布【行业研究】",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-04-12",
            "original_text": "财政部出手！清查药企“带金销售”，剑指药价虚高，涉及多家上市公司。",
            "features": {
                "keywords": [
                    "财政部",
                    "带金销售",
                    "药价虚高",
                    "上市公司"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "财政部出手！清查药企“带金销售”，剑指药价虚高，涉及多家上市公司。",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-04-12",
            "original_text": "国信证券——医药行业一周观察：关注财报季投资机会，第四批药品集采即将落地执行【行业研究】",
            "features": {
                "keywords": [
                    "国信证券",
                    "医药行业",
                    "财报季",
                    "药品集采"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "国信证券——医药行业一周观察：关注财报季投资机会，第四批药品集采即将落地执行【行业研究】",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-04-12",
            "original_text": "19家药企被处罚，4700亿龙头在列，更有全球医药巨头。",
            "features": {
                "keywords": [
                    "药企处罚",
                    "龙头公司",
                    "全球医药巨头"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "19家药企被处罚，4700亿龙头在列，更有全球医药巨头。",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-04-12",
            "original_text": "光大证券——医药生物行业跨市场周报：财报季医药行情有望持续，重视具备三大特质的细分赛道【行业研究】",
            "features": {
                "keywords": [
                    "光大证券",
                    "医药生物",
                    "财报季",
                    "细分赛道"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "光大证券——医药生物行业跨市场周报：财报季医药行情有望持续，重视具备三大特质的细分赛道【行业研究】",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-04-12",
            "original_text": "A股融资融券日报：两融余额减少31.16亿元（4月12日）。",
            "features": {
                "keywords": [
                    "A股",
                    "融资融券",
                    "两融余额"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额减少31.16亿元（4月12日）。",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        }
    ]
]